V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215036 | 20168357 | 1.71 | 53.05 | null | 2017-03-23 | 2017-04-05 | GEMCITABINE + NAB PACLITAXEL | N | null | CAPECITABINE + CARBOPLATIN | 101450021 |
| 20215049 | 20168359 | 1.76 | 70.8 | Palliative (P) | 2019-03-02 | 2019-03-02 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101655671 |
| 20215050 | 20168360 | 1.88 | 83 | Palliative (P) | 2020-10-02 | 2021-02-27 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100159587 |
| 20215052 | 20168361 | 1.72 | 94.3 | null | 2015-10-28 | 2016-02-21 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101748537 |
| 20215053 | 20168362 | 1.76 | 64.4 | null | 2022-01-19 | 2022-01-19 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100815574 |
| 20215058 | 20168363 | 1.73 | 76 | Palliative (P) | 2020-08-26 | 2020-09-10 | GEMCITABINE + NAB PACLITAXEL | N | N | GEMCITABINE + NAB-PACLITAXEL | 100328862 |
| 20215068 | 20168365 | 1.84 | 87.8 | Palliative (P) | 2020-01-12 | 2020-01-12 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100778076 |
| 20215071 | 20168366 | 1.65 | 72.4 | Palliative (P) | 2019-05-06 | 2019-12-21 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | N | N | CAPECITABINE + CARBOPLATIN | 101475060 |
| 20215076 | 20168367 | 1.76 | 83.6 | null | 2021-12-16 | 2021-12-31 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100048467 |
| 20215077 | 20168368 | 1.81 | 105.7 | Palliative (P) | 2019-10-02 | 2019-10-10 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100987567 |
| 20215078 | 20168369 | 1.55 | 92 | null | 2018-11-23 | 2019-01-14 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100591288 |
| 20215082 | 20168370 | 1.76 | 79 | Curative (C) | 2019-12-24 | 2020-01-07 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101651174 |
| 20215084 | 20168371 | 1.74 | 59.1 | null | 2017-12-18 | 2019-09-03 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100017471 |
| 20215090 | 20168372 | 1.72 | 59.2 | Palliative (P) | 2018-12-05 | 2019-02-19 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101806635 |
| 20215097 | 20168373 | 1.44 | 51.6 | Palliative (P) | 2017-11-20 | 2017-11-24 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101284377 |
| 20215106 | 20168374 | 1.84 | 43.4 | Palliative (P) | 2022-03-05 | 2022-03-23 | CAPECITABINE + CARBOPLATIN | null | N | CAPECITABINE + CARBOPLATIN | 101314334 |
| 20215109 | 20168375 | null | null | null | 2022-01-13 | 2022-02-04 | null | null | null | ECX | 101705105 |
| 20215126 | 20168376 | 1.72 | 73.15 | null | 2018-09-01 | 2018-09-01 | null | 2 | null | CISPLATIN + FLUOROURACIL | 101584161 |
| 20215134 | 20168377 | null | 87 | Neo-adjuvant (N) | 2020-08-31 | 2020-09-18 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100202876 |
| 20215154 | 20168378 | 1.68 | 51.6 | null | 2018-07-07 | 2018-07-28 | ECX | 02 | null | ECX | 100575560 |
| 20215159 | 20168380 | 1.93 | 66.5 | 03 | 2020-01-31 | 2020-01-31 | null | N | null | ECX | 101172881 |
| 20215165 | 20168381 | 1.61 | 77.65 | Neo-adjuvant (N) | null | 2021-08-22 | ECX | N | Y | ECX | 100187047 |
| 20215169 | 20168382 | 1.69 | 50.9 | null | 2018-01-11 | 2018-01-15 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100785299 |
| 20215179 | 20168383 | null | 50.6 | null | 2017-04-10 | 2019-09-06 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101663089 |
| 20215189 | 20168384 | 1.82 | 53.1 | Palliative (P) | 2020-02-14 | 2020-03-13 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101558632 |
| 20215191 | 20168385 | 1.62 | 83.5 | null | null | 2017-03-18 | ECX | N | null | ECX | 100148502 |
| 20215192 | 20168386 | 1.52 | 80 | null | 2020-02-22 | 2020-03-05 | Carboplatin + Etoposide iv&po | 02 | null | CARBOPLATIN + ETOPOSIDE | 101661841 |
| 20215194 | 20168387 | 1.69 | 123.5 | Palliative (P) | 2021-08-03 | 2021-10-03 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101774733 |
| 20215203 | 20168388 | 1.7 | 98 | null | null | 2021-10-05 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101820639 |
| 20215205 | 20168389 | 1.52 | 83.4 | null | 2015-12-26 | 2016-06-14 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101605789 |
| 20215210 | 20168391 | 1.74 | 73.4 | Curative (C) | 2019-07-23 | 2019-07-29 | Panitumumab | N | N | PANITUMUMAB | 101350211 |
| 20215211 | 20168392 | 1.78 | 43 | null | null | 2020-12-20 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100797482 |
| 20215217 | 20168393 | 1.53 | null | Neo-adjuvant (N) | null | 2018-09-13 | null | 02 | N | ECX | 101077415 |
| 20215229 | 20168394 | 1.67 | 95.7 | null | 2022-01-26 | 2022-02-04 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100418435 |
| 20215235 | 20168396 | 1.61 | 78.4 | null | 2021-04-23 | 2021-05-15 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100631339 |
| 20215236 | 20168397 | 1.76 | 31.1 | null | 2018-01-19 | 2018-01-28 | null | null | null | PANITUMUMAB | 100010670 |
| 20215238 | 20168398 | null | null | null | null | 2020-08-01 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101305267 |
| 20215260 | 20168400 | 1.61 | 68.9 | null | null | 2019-07-29 | ECX | null | null | ECX | 101816024 |
| 20215266 | 20168402 | 1.66 | 56.8 | Palliative (P) | null | 2022-01-23 | NIVOLUMAB | null | N | NIVOLUMAB | 100084391 |
| 20215276 | 20168404 | 1.52 | 73.8 | null | 2017-11-10 | 2017-11-24 | Carboplatin + Etoposide iv&po | 02 | null | CARBOPLATIN + ETOPOSIDE | 101214701 |
| 20215278 | 20168405 | null | null | Palliative (P) | 2021-11-27 | 2021-12-14 | Panitumumab | 2 | N | PANITUMUMAB | 100168435 |
| 20215281 | 20168406 | null | 74.8 | null | 2017-03-07 | 2017-03-07 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100433127 |
| 20215296 | 20168407 | 1.54 | 78 | null | null | 2018-07-10 | ECX | N | null | ECX | 100967309 |
| 20215306 | 20168408 | 1.73 | 59.1 | null | 2019-09-22 | 2019-10-15 | CISPLATIN + FLUOROURACIL | 2 | null | CISPLATIN + FLUOROURACIL | 100856600 |
| 20215318 | 20168409 | null | 66.2 | Neo-adjuvant (N) | null | 2017-06-01 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101365667 |
| 20215319 | 20168410 | 1.81 | 69 | null | 2016-04-28 | 2016-05-31 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100558155 |
| 20215328 | 20168411 | 1.7 | 78.5 | null | 2020-12-14 | 2021-01-08 | Carboplatin + Etoposide iv&po | 02 | null | NIVOLUMAB | 100874783 |
| 20215329 | 20168412 | null | null | Palliative (P) | null | 2020-06-17 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101630768 |
| 20215335 | 20168413 | 1.67 | 51 | null | 2021-05-06 | 2021-05-16 | Panitumumab | N | Y | PANITUMUMAB | 101038282 |
| 20215343 | 20168415 | 1.67 | null | null | 2019-10-13 | 2019-10-15 | Cisplatin +Fluorouracil (3 wk) | N | null | CISPLATIN + FLUOROURACIL | 101695982 |